Clinical Trial Update: Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a simplified, low-dose tacrolimus (Envarsus XR) immunosuppressive protocol in kidney transplantation; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection
• Kidney Transplantation

Drugs mentioned

• Envarsus XR (Tacrolimus)

Snippet

Sponsor: University of Southern California | Conditions: Kidney Transplantation, Kidney Transplant Rejection | Phase 4 | Status: TERMINATED